Summary

Cerus Corporation (Cerus) is a biomedical products manufacturing company. It undertakes the development and commercialization of novel, proprietary products and technologies, intended to make the blood supply safer. The company focuses on the development and commercialization of its flagship INTERCEPT Blood System based on its proprietary Helinx technology. Cerus has the worldwide rights of INTERCEPT for three blood components: platelets, red blood cells and plasma. The system is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells (WBC) included in donated blood components intended for transfusion. It is marketed in Europe, Russia, the Middle East and selected countries of other regions of the world for the treatment of both platelets and plasma for transfusions and it is also being developed for the treatment of red blood cells. Cerus is headquartered in Concord, California, the US.

Cerus Corporation (CERS) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cerus Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Cerus Corporation, Medical Equipment Deals By Type, 2008 to YTD 2014 6
Cerus Corporation, Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Cerus Corporation, Medical Equipment, Deals By Market, 2008 to YTD 2014 8
Cerus Corporation, Medical Equipment, Deals Summary, 2008 to YTD 2014 9
Cerus Corporation, Medical Equipment, Deal Details 10
Partnerships 10
Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 10
Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 11
Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 12
Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 13
Cerus Enters Into Distribution Agreement With Ilex Biotech 14
Cerus Enters Into Agreement With CSL 15
Cerus Enters Into An Agreement With Grifols 16
Cerus Enters Into Co-Development Agreement With German Red Cross 17
Equity Offering 18
Cerus Files Registration Statement for Public Offering of Securities for up to USD261 Million 18
Cerus Completes Public Offering Of Shares For US$40.3 Million 19
Cerus Completes Underwritten Public Offering Of US$21 Million 21
Cerus Completes Private Placement Of Units For US$13.2 Million 23
Cerus Corporation - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Other Locations and Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Cerus Corporation, Medical Equipment, Key Facts, 2013 1
Cerus Corporation, Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Cerus Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Cerus Corporation, Medical Equipment Deals By Type, 2008 to YTD 2014 6
Cerus Corporation, Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Cerus Corporation, Deals By Market, 2008 to YTD 2014 8
Cerus Corporation, Medical Equipment, Deals Summary, 2008 to YTD 2014 9
Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 10
Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 11
Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 12
Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 13
Cerus Enters Into Distribution Agreement With Ilex Biotech 14
Cerus Enters Into Agreement With CSL 15
Cerus Enters Into An Agreement With Grifols 16
Cerus Enters Into Co-Development Agreement With German Red Cross 17
Cerus Files Registration Statement for Public Offering of Securities for up to USD261 Million 18
Cerus Completes Public Offering Of Shares For US$40.3 Million 19
Cerus Completes Underwritten Public Offering Of US$21 Million 21
Cerus Completes Private Placement Of Units For US$13.2 Million 23
Cerus Corporation, Key Competitors 25
Cerus Corporation, Key Employees 26
Cerus Corporation, Subsidiaries 27

List of Figures
Cerus Corporation, Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Cerus Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Cerus Corporation, Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Cerus Corporation, Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Cerus Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Cerus Corporation, Medical Equipment, Deals by Type, 2008 to YTD 2014 6
Cerus Corporation, Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Cerus Corporation, Medical Equipment, Deals by Market, 2008 to YTD 2014 8

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Transfusion & Transplantation Technologies - Product Pipeline Analysis, 2014 Update

Transfusion & Transplantation Technologies - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Transfusion & Transplantation Technologies (3Ti) is a diagnostic company. The company develops automated technology for the diagnostic testing of blood associated with blood transfusions. Its flagship ...

ApaTech Limited SWOT Analysis, Strategy, Revenues and Profits

ApaTech Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Kedrion Group S.p.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kedrion Group S.p.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Kedrion S.p.A. (Kedrion) is a biopharmaceutical company. It focuses on collecting and fractionating blood plasma for the production and distribution of plasma-derived therapeutic products. Its ...

Cord Blood America, Inc.

October 2014 $ 55

Glycorex Transplantation Ab

November 2014 $ 55

Cord Blood America Inc

December 2014 $ 55

Adtec Plasma Technology Co Ltd

December 2014 $ 55

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.